Last reviewed · How we verify

NCT03532672

Early Effect of Fasting on Metabolic, Inflammatory, and Behavioral Responses in Females With and Without Obesity

Completed NA Last updated 21 March 2025
What this trial tests

NA trial testing Acute Fasting in Healthy in 54 participants. Completed in 31 December 2022.

Timeline
22 September 2017
Primary endpoint
26 March 2019
31 December 2022

Quick facts

Lead sponsorFederal University of Minas Gerais
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment54
Start date22 September 2017
Primary completion26 March 2019
Estimated completion31 December 2022
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Federal University of Minas Gerais

Who can join

Adults 18 to 60, female only, with Healthy or Obese. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the effect of overnight fasting versus a diurnal fasting (during daily life activities) in females with and without obesity on inflammation, neurotrophins, energy metabolism, mood, food cravings, and appetite sensations. This study will be an acute fasting intervention.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of a single 10-hour daytime fasting intervention on mood and appetite in female adults with and without obesity: a real-world feasibility trial.
    Tibaes JRB, Fagundes GB, Martins LB, Rodrigues AMDS, et al · · 2025 · PMID 40491423 · DOI 10.1080/1028415x.2025.2514490

Verify or expand the search:

Other trials of Acute Fasting

Trials testing the same drug.

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Federal University of Minas Gerais trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03532672.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing